Founded by Ronald Koning, with almost 40 years of clinical and clinical development experience following graduation as MD in 1985 from Erasmus University Rotterdam, Netherlands.

Experience across all stages of drug development and most therapeutic area’s.

Building and leading world class Early Phase Clinics and leading complex organizations.

Big Pharma, global leading Biotech, CROs.

Most recent experience ( 2012-2023 ) as VP Europe and Managing Director, Early Phase Services, for Global CRO ICON ( formerly PRA HealthSciences ), including direct responsibilities for state of the art Clinical research Units units in the Netherlands, Prague and Budapest, CRO services, GMP Manufacturing, Clinical Chemistry Laboratory, including all financial, legal , IT , Facilities and HR aspects in a matrix environment, Director for the Works Council. Statutory responsibility for all legal entities. Designated spokes person. Business Continuity Team lead. Member of multiple Governance structures with partnership clients. Up to 700 highly qualified staff members.

Biologics, Biosimilars, First in Human, POC, Clinical Pharmacology studies, radio labeled studies. Inspected by FDA, EMA, GCP and GMP regulatory authorities.